An earlier study reported that GSK-3β promotes the survival and proliferation of osteosarcoma cells as well as their insensitivity to conventional chemotherapy [25], based on the known role for GSK-3β in positively regulating NF-κB-mediated signaling [35, 36]. This evidence concerns the gene NFKB1 and osteosarcoma.